📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Immunovia

1.1 - Company Overview

Immunovia Logo

Immunovia

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of blood-based diagnostics for early detection of pancreatic cancer, conducting clinical trials and validation studies to ensure accuracy and reliability, and collaborating with medical institutions and research centers globally to validate its diagnostic tests and bring them to market.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Immunovia

ArcherDX Logo

ArcherDX

HQ: United States Website
  • Description: Provider of NGS-based assay solutions advancing molecular pathology, using proprietary Anchored Multiplex PCR (AMP) chemistry and Archer Analysis software to detect genetic mutations for solid tumor, blood cancer, and genetic disease research. Offers VARIANTPlex DNA panels, FUSIONPlex RNA panels, LIQUIDPlex ctDNA panels, IMMUNOVerse immune profiling assays, and an Assay Marketplace for custom NGS panels.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ArcherDX company profile →
Linnaeus Therapeutics Logo

Linnaeus Therapeutics

HQ: United States Website
  • Description: Provider of development-stage cancer therapeutics, including LNS8801, an orally bioavailable, highly specific G protein-coupled estrogen receptor (GPER) agonist that depletes c-Myc protein levels, shows antitumor activities in preclinical cancer models, and is being tested in clinical trials as a monotherapy and with pembrolizumab.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Linnaeus Therapeutics company profile →
Synimmune Logo

Synimmune

HQ: Germany Website
  • Description: Provider of innovative mono- and bispecific anti-tumor antibodies for treating life-threatening diseases, focusing on orphan hematopoietic malignancies; lead product candidate is the antibody FLYSYN.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synimmune company profile →
Kuur Therapeutics Logo

Kuur Therapeutics

HQ: United Kingdom Website
  • Description: Provider of off-the-shelf engineered CAR-NKT cell therapies, combining the natural biology of natural killer T cells with innovative CAR constructs for cancer treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kuur Therapeutics company profile →
Medifocus Logo

Medifocus

HQ: United States Website
  • Description: Provider of minimally invasive treatment systems for cancerous and benign tumors and enlarged prostate (BPH), developing and commercializing solutions based on two technology platforms with approximately 100 issued and pending US and international patents.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medifocus company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Immunovia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Immunovia

2.2 - Growth funds investing in similar companies to Immunovia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Immunovia

4.2 - Public trading comparable groups for Immunovia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Immunovia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Immunovia

What does Immunovia do?

Immunovia is a provider of blood-based diagnostics for early detection of pancreatic cancer, conducting clinical trials and validation studies to ensure accuracy and reliability, and collaborating with medical institutions and research centers globally to validate its diagnostic tests and bring them to market.

Who are Immunovia's competitors?

Immunovia's competitors and similar companies include ArcherDX, Linnaeus Therapeutics, Synimmune, Kuur Therapeutics, and Medifocus.

Where is Immunovia headquartered?

Immunovia is headquartered in Sweden.

How many employees does Immunovia have?

Immunovia has 1,000 employees 🔒.

When was Immunovia founded?

Immunovia was founded in 2010 🔒.

What sector and industry vertical is Immunovia in?

Immunovia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Immunovia

Who are the top strategic acquirers in Immunovia's sector and industry

Top strategic M&A buyers and acquirers in Immunovia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Immunovia?

Top strategic M&A buyers groups and sectors for Immunovia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Immunovia's sector and industry vertical

Which are the top PE firms investing in Immunovia's sector and industry vertical?

Top PE firms investing in Immunovia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Immunovia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Immunovia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Immunovia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Immunovia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Immunovia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Immunovia?

The key public trading comparables and valuation benchmarks for Immunovia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Immunovia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Immunovia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Immunovia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Immunovia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Immunovia's' sector and industry vertical?

Access recent funding rounds and capital raises in Immunovia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Immunovia